Skip to content

AbbVie

US · ABBV #24 by market cap Listed 1970 AI Rating C 62
256.46 -3.75 -1.44%
Collector offline (last heartbeat: 15926s ago) · 2026-09-04 20:02
Pre-market 259.19 -0.39%
After-hours 256.53 +0.03%
Overnight 259.13 -0.42%
Mkt cap
453.19B
P/B
-76.35
EPS
2.36

Recent news

  • BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $300
    Market Newswire · 9/4
  • Scotiabank Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
    Market Newswire · 9/4
  • TD Cowen Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $280
    Market Newswire · 9/4
  • AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Michael Robert A.
    SEC · 2/21
  • Guggenheim Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $288
    Market Newswire · 8/4
  • Haisike: Announcement on Signing a License Agreement for Nav1.8 Inhibitor with AbbVie
    SZSI · 4/13
  • AbbVie 2Q U.S. HUMIRA Rev $425M ABBV
    Dow Jones · 7/31
  • Erste Group Upgrades AbbVie(ABBV.US) to Buy Rating
    Market Newswire · 8/5
  • News On Apogee Therapeutics Inc. (APGE) Now Under ABBV
    Dow Jones · 9/4
  • Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $303
    Market Newswire · 8/20
  • 4: AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Davis Jennifer L.
    SEC · 5/13
  • AbbVie | 4: Statement of changes in beneficial ownership of securities-Director BURNSIDE WILLIAM H.L.
    SEC · 5/13
  • AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Michael Robert A.
    SEC · 3/4

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-09-04 20:02:13 · For reference only, not investment advice.